Don’t give kids under 6 cold medicine, government says
The over-the-counter medicines should be studied further, even after decades in which children have received billions of doses a year, the outside experts told the Food and Drug Administration. The FDA isn’t required to follow the advice of its panels of outside experts but does so most of the time.
‘The data that we have now is they don’t seem to work,’ said Sean Hennessy, a University of Pennsylvania epidemiologist, one of the FDA experts gathered to examine the medicines sold to treat common cold symptoms. The recommendation applies to medicines containing one or more of the following ingredients: decongestants, expectorants, antihistamines and antitussives.
The nonbinding recommendation is likely to lead to a shake up in how the medicines ‘ which have long escaped much scrutiny ‘ are labeled, marketed and used. Just how and how quickly wasn’t immediately clear.
In two separate votes, the panelists said the medicines shouldn’t be used in children younger than 2 or in those younger than 6. A third vote, to recommend against use in children 6 to 11, failed.
Simply relabeling the medicines to state they shouldn’t be used in some age groups could be accomplished rather quickly, FDA officials said.
Indeed, the drug industry could further revise the labels on the medicines to caution against such use. The Thursday-Friday meeting came just a week after the industry pre-emptively moved to eliminate sales of the nonprescription drugs targeted at children under 2.
Pediatricians pushing for greater restrictions told the FDA advisers Thursday that the over-the-counter medicines shouldn’t be given to children younger than 6, a group they called most vulnerable to any potential ill effects.
But FDA officials and panelists agreed there’s no evidence they work in older children, either. Still, panelists held off from recommending against use in older children.
The drug industry says the medicines, used 3.8 billion times a year in treating cold and cough symptoms in children, do work and are safe. It says that more parent education is needed to avoid overdoses that in rare cases have been fatal.
An American Academy of Pediatrics official earlier Friday told the experts the medications should be relabeled to tell parents they don’t work in children under 6 and may be dangerous.
Some of the drugs ‘ which include Wyeth’s Dimetapp and Robitussin, Johnson & Johnson’s Pediacare and Novartis AG’s Triaminic products ‘ have never been tested in children.
One health expert told the panel that children catch five to eight colds each year. Those colds don’t necessarily require treatment beyond comfort measures that don’t involve drugs, said Patricia Jackson Allen, of the National Association of Pediatric Nurse Practitioners.
